PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Trace amounts of microbe-killing molecules predict chronic granulomatous disease survival

NIH study could improve care for chronic granulomatous disease

2010-12-30
(Press-News.org) Investigators at the National Institutes of Health have observed that the survival rate of people with a rare immunodeficiency disease called chronic granulomatous disease (CGD) is greatly improved when even very low levels of microbe-killing molecules are present. Because production of these molecules, made by an enzyme called NADPH oxidase, can be predicted from genetic analysis, a patient's risk for severe CGD could be assessed very early in life, allowing for more personalized treatment, say the researchers. The study was conducted at the NIH Clinical Center and led by researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, and their associated contract labs at SAIC-Frederick Inc. The study is available online in the New England Journal of Medicine. "Advances in treatment of CGD have made it possible for people with this once-fatal disease of early childhood to survive into adulthood; however, the disease remains difficult to manage," says NIAID Director Anthony S. Fauci, M.D. "Having a marker to help predict disease prognosis will enable physicians to recommend treatment options that are more tailored to the needs of individual patients." People with CGD have increased susceptibility to infections caused by certain bacteria, such as Staphylococcus aureus, and fungi, such as Aspergillus. They can have abscesses in the lungs, liver, spleen, bones or skin. Those with severe disease also can have tissue masses, called granulomas, which can obstruct the bowel or urinary tract. CGD affects an estimated 1,200 people in the United States and approximately 25,000 people worldwide. The disease is caused by inherited mutations in any one of five different genes required by immune cells to make the NADPH oxidase enzyme, which in turn makes superoxide, an oxygen-derived molecule that immune cells use to destroy harmful bacteria and fungi. All CGD patients have impaired superoxide production. Some make a little superoxide, while others make none. The research team found that the level of superoxide production was linked to the type of mutation in the NADPH oxidase gene, and that the more superoxide a patient with CGD can make, the less severe the disease and the greater the life expectancy. Until now, the severity of CGD has been linked only to how people inherit the NADPH oxidase gene mutation. If people inherit the mutation as an autosomal recessive trait, meaning that two copies of the abnormal gene, one from each parent, are present, the disease has generally been less severe than in those who inherit the mutation as an X-linked trait, meaning that the abnormal gene is located on the female sex chromosome. The majority of people with CGD inherit the mutation as an X-linked trait. For their study, the NIH team tested the level of superoxide production by immune cells isolated from blood samples taken from 287 people with CGD, aged 1 to 64 years old, compared with superoxide production in healthy people. Some tests dated back to 1993, though patients and families affected by CGD have come to the NIH Clinical Center for treatment since the 1970s. The NIH researchers used methods that could detect even trace amounts of superoxide, and grouped people with CGD based on the amount of superoxide made by the immune cells. The patients who produced the highest levels of superoxide had the highest survival rates, whereas those who produced the lowest levels of superoxide had the lowest survival rates. "By precisely measuring superoxide production, we observed that even tiny residual amounts, at levels below what doctors paid attention to in the past, had a significant impact on patient survival," says John Gallin, M.D., director of the NIH Clinical Center, chief of the Clinical Pathophysiology Section of the NIAID Laboratory of Host Defenses, and senior author on the paper. Treatment of CGD consists of lifelong antibiotics and antifungal medications. Some people also receive injections with interferon-gamma, a protein that can stimulate the immune cells to fight infections. For people with the most severe forms of CGD, bone marrow transplantation is a treatment option, but it carries potential complications that can make patients and their families reluctant to elect this therapy. Based on the research team's observations, doctors should be able to use DNA gene-typing results to help identify those patients who are candidates for more aggressive treatments, including possible bone marrow transplantation. Bone marrow transplantation replaces the immune cells of people with CGD, which produce no or reduced amounts of microbe-killing superoxide, with healthy immune cells. In addition, therapies designed to promote NADPH oxidase function might reduce CGD severity. Therapies exist to stimulate NADPH oxidase but none are used to treat CGD. "This study is a great example of the special strengths of the Clinical Center," comments Dr. Gallin. "We have worked for over three decades with patients with CGD, which at one time was almost entirely fatal, and have seen vast improvements in care and treatment. This work now gives us another tool to help individuals fight this disease." INFORMATION:

Additional support for this research was provided by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Cancer Institute, also components of NIH, and SAIC-Frederick Inc. NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at www.niaid.nih.gov. NIDDK, a component of the NIH, conducts and supports research in diabetes and other endocrine and metabolic diseases; digestive diseases, nutrition, and obesity; and kidney, urologic, and hematologic diseases. Spanning the full spectrum of medicine and afflicting people of all ages and ethnic groups, these diseases encompass some of the most common, severe, and disabling conditions affecting Americans. For more information about NIDDK and its programs, see www.niddk.nih.gov. NCI leads the National Cancer Program and the NIH effort to dramatically reduce the burden of cancer and improve the lives of cancer patients and their families, through research into prevention and cancer biology, the development of new interventions, and the training and mentoring of new researchers. For more information about cancer, please visit the NCI Web site at www.cancer.gov or call NCI's Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). The National Institutes of Health (NIH)—The Nation's Medical Research Agency—includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

Reference: DB Kuhns et al. Residual NADPH oxidase and survival in chronic granulomatous disease. New England Journal of Medicine. DOI: 10.1056/NEJMoa1007097 (2010).



ELSE PRESS RELEASES FROM THIS DATE:

UNC scientists pinpoint link between light signal and circadian rhythms

2010-12-30
Chapel Hill, NC – In a new paper published this week in the Proceedings of the National Academy of Sciences, Aziz Sancar, MD, PhD, the Sarah Graham Kenan Professor of Biochemistry and Biophysics in the UNC School of Medicine, and his colleagues have taken an important step in understanding the underlying molecular signals that influence a broad array of biological processes ranging from the sleep-wake cycle to cancer growth and development. Scientists who work in this field, known as chronobiology, have identified the genes that direct circadian rhythms in people, mice, ...

Hybrid string blossom thinner tested in peach orchards

Hybrid string blossom thinner tested in peach orchards
2010-12-30
GETTYSBURG, PA – Peach producers have traditionally relied heavily on hand thinning, a necessary but costly and labor-intensive field practice. Impacted by increasing labor costs and a limited workforce, peach and other stone fruit growers are turning to mechanical methods such as string thinners to minimize the need for hand thinning. A new ''hybrid'' string thinner prototype showed promising results when it was evaluated in four U.S. growing regions; the trials resulted in significant labor savings and increased peach size. According to Pennsylvania State University's ...

Genetic relationship between Hungarian and Turkish apricots confirmed

Genetic relationship between Hungarian and Turkish apricots confirmed
2010-12-30
BUDAPEST, HUNGARY – Apricots are important to Turkey, the country where more apricot crops are grown and exported than anywhere in the world. Looking to unlock the mystery of apricots' origins and increase crop production, scientists are studying the genetic relationship between apricot varieties. New research from a team of Hungarian and Turkish scientists has confirmed the genetic link between Turkish and Hungarian apricot cultivars, yielding information that provides valuable data for apricot growers and breeders. It is widely believed that apricots originated in China, ...

Turfgrass fertility, pesticide programs compared

Turfgrass fertility, pesticide programs compared
2010-12-30
WEST LAFAYETTE, IN – Traditional turfgrass management programs rely heavily on the use of synthetic pesticides and fertilizers. In response to increased public scrutiny and legislation, organic and biological alternatives are becoming more accepted, but research indicates that these alternatives have not been widely adopted by either homeowners or the lawn care industry. Results of a new study that compared common but disparate turfgrass management approaches may help lawn care professionals to evaluate, market, and implement alternative management programs. Purdue University ...

Indoor plant intervention: New answers for health care design?

Indoor plant intervention: New answers for health care design?
2010-12-30
NORWAY – Could a plant "intervention" improve the well-being of patients in a difficult rehab process? Scientists from the Norwegian University of Life Sciences and Sweden's Uppsala University investigated this question in a recent study of 436 coronary and pulmonary patients at a Norwegian rehabilitation center. The results were published in HortScience. Ruth Kjærsti Raanaas, Grete Grindal Patil, and Terry Hartig studied the effects of an indoor plant intervention during a 2-year study conducted at the Røros Rehabilitation Center. The experiment showed that patients' overall ...

Children in areas with few pediatricians at higher risk for serious appendix ruptures

Children in areas with few pediatricians at higher risk for serious appendix ruptures
2010-12-30
Children who live in areas with fewer pediatricians are more likely to suffer life-threatening ruptures of the appendix than those in areas with more pediatricians, even when accounting for other factors such as the number of hospitals, imaging technology, insurance coverage and the number of surgeons in an area, according to a study from the Johns Hopkins Children's Center. The study's findings, based on an analysis of nearly 250,000 hospital records of children with appendicitis, are published online in the December issue of JAMA-Archives of Surgery. "Our analysis ...

Protein involved in cystic fibrosis also plays role in emphysema, chronic lung disease

Protein involved in cystic fibrosis also plays role in emphysema, chronic lung disease
2010-12-30
A team of Johns Hopkins Children's Center researchers has discovered that a protein involved in cystic fibrosis (CF) also regulates inflammation and cell death in emphysema and may be responsible for other chronic lung diseases. The findings, published online in the December issue of The Journal of Immunology, pave the way toward new treatments to prevent lung damage caused by infections or cigarette smoke in emphysema. The protein, called CFTR (cystic fibrosis transmembrane conductance regulator), is already well known for its role in transporting chloride in and ...

Coma and general anesthesia demonstrate important similarities

2010-12-30
NEW YORK (Dec. 30, 2010) -- The brain under general anesthesia isn't "asleep" as surgery patients are often told -- it is placed into a state that is a reversible coma, according to three neuroscientists who have published an extensive review of general anesthesia, sleep and coma, in the Dec. 30 issue of the New England Journal of Medicine. This insight and others reported in their review article could eventually lead to new approaches to general anesthesia and improved diagnosis and treatment for sleep abnormalities and emergence from coma. The researchers explain that ...

Longevinex exhibits L-shaped safety curve for first time in resveratrol biology

2010-12-30
Las Vegas, Nevada (Dec. 30, 2010) – It was Paracelsus, the Renaissance physician (1493-1541 A.D.) who first said "the dose makes the poison." So, you can drink too much wine, or ingest too much resveratrol, but in an unprecedented study, heart researchers report they couldn't find a toxic dose for Longevinex®, a resveratrol-based dietary supplement. Investigators previously reported that six or more glasses of red wine per day actually increase the risk, whereas 3-5 glasses per day optimally reduce risk for cardiac death. This is the well-known J-shaped risk curve ...

Merrill DataSite Captures Repeat Industry Honors as "Product/Service of the Year"

2010-12-30
Merrill Corporation (www.merrillcorp.com), a leading provider of technology-enabled services, is pleased to announce that Merrill DataSite was named "Product/Service of the Year" for the second year in a row at the at the 9th Annual M&A Awards, presented by the M&A Advisor. The awards gala, which honors professionals in the mergers and acquisition industry, took place at the New York Athletic Club on Dec. 14, 2010. The M&A Awards honored deal-teams, dealmakers, and firms whose activities set the standard for the industry. This year, 243 finalists in 47 categories were ...

LAST 30 PRESS RELEASES:

Evolution of fast-growing fish-eating herring in the Baltic Sea

Cryptographic protocol enables secure data sharing in the floating wind energy sector

Can drinking coffee or tea help prevent head and neck cancer?

Development of a global innovative drug in eye drop form for treating dry age-related macular degeneration

Scientists unlock secrets behind flowering of the king of fruits

Texas A&M researchers illuminate the mysteries of icy ocean worlds

Prosthetic material could help reduce infections from intravenous catheters

Can the heart heal itself? New study says it can

Microscopic discovery in cancer cells could have a big impact

Rice researchers take ‘significant leap forward’ with quantum simulation of molecular electron transfer

Breakthrough new material brings affordable, sustainable future within grasp

How everyday activities inside your home can generate energy

Inequality weakens local governance and public satisfaction, study finds

Uncovering key molecular factors behind malaria’s deadliest strain

UC Davis researchers help decode the cause of aggressive breast cancer in women of color

Researchers discovered replication hubs for human norovirus

SNU researchers develop the world’s most sensitive flexible strain sensor

Tiny, wireless antennas use light to monitor cellular communication

Neutrality has played a pivotal, but under-examined, role in international relations, new research shows

Study reveals right whales live 130 years — or more

Researchers reveal how human eyelashes promote water drainage

Pollinators most vulnerable to rising global temperatures are flies, study shows

DFG to fund eight new research units

Modern AI systems have achieved Turing's vision, but not exactly how he hoped

Quantum walk computing unlocks new potential in quantum science and technology

Construction materials and household items are a part of a long-term carbon sink called the “technosphere”

First demonstration of quantum teleportation over busy Internet cables

Disparities and gaps in breast cancer screening for women ages 40 to 49

US tobacco 21 policies and potential mortality reductions by state

AI-driven approach reveals hidden hazards of chemical mixtures in rivers

[Press-News.org] Trace amounts of microbe-killing molecules predict chronic granulomatous disease survival
NIH study could improve care for chronic granulomatous disease